A framework for in vitro systems toxicology assessment of e-liquids

Toxicology Mechanisms and Methods

Volumn 26, Issue 6, 2016, Pages 389-413

  Iskandar, Anita R ^a   Gonzalez Suarez, Ignacio ^a   Majeed, Shoaib ^a   Marescotti, Diego ^a   Sewer, Alain ^a   Xiang, Yang ^a   Leroy, Patrice ^a   Guedj, Emmanuel ^a   Mathis, Carole ^a   Schaller, Jean Pierre ^a   Vanscheeuwijck, Patrick ^a   Frentzel, Stefan ^a   Martin, Florian ^a   Ivanov, Nikolai V ^a   Peitsch, Manuel C ^a   Hoeng, Julia ^a  

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

Author keywords

e Cigarette; ENDS; high content screening; organotypic cultures transcriptomics

Indexed keywords

ACCURACY; AEROSOL; AIR; ARTICLE; CONTROLLED STUDY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; LIQUID; PRIMARY CELL CULTURE; PRIORITY JOURNAL; STANDARD; TOXICOLOGY; ADVERSE EFFECTS; AIR POLLUTANT; CELL CULTURE; CELL CULTURE TECHNIQUE; CELL SURVIVAL; DEVICES; DRUG EFFECTS; ELECTRONIC CIGARETTE; EQUIPMENT DESIGN; PROCEDURES; SYSTEMS BIOLOGY; TOXICITY; TOXICITY TESTING; VOLATILIZATION;

AEROSOL; AIR POLLUTANT;

AEROSOLS; AIR POLLUTANTS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CELLS, CULTURED; ELECTRONIC CIGARETTES; EQUIPMENT DESIGN; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; SYSTEMS BIOLOGY; TOXICITY TESTS; VOLATILIZATION;

EID: 84982923044     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2016.1170251     Document Type: Article

References (102)

1. A.P.Albino, X.Huang, E.Jorgensen,. (2004). Induction of H2AX phosphorylation in pulmonary cells by tobacco smoke:a new assay for carcinogens. Cell Cycle 3:1062–8.
2. M.Balls (2010). ATLA (Alternatives to Laboratory Animals):past, present and future. Altern Lab Anim 38:437–41.
3. R.Z.Behar, M.Hua, P.Talbot (2015). Puffing topography and nicotine intake of electronic cigarette users. PLoS One 10:e0117222.
4. N.Berg, B.De Wever, H.W.Fuchs,. (2011). Toxicology in the 21st century-working our way towards a visionary reality. Toxicol In Vitro 25:874–81.
5. M.Bijanzadeh, N.B.Ramachandra, P.A.Mahesh,. (2009). Soluble intercellular adhesion molecule-1 and E-selectin in patients with asthma exacerbation. Lung 187:315–20.
6. S.Boué, M.Talikka, J.W.Westra,. (2015). Causal biological network database:a comprehensive platform of causal biological network models focused on the pulmonary and vascular systems. Database 2015.
7. T.H.Brandon, M.L.Goniewicz, N.H.Hanna,. (2015). Electronic nicotine delivery systems:a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology. J Clin Oncol 33:952–63.
8. C.J.Brown, J.M.Cheng (2014). Electronic cigarettes:product characterisation and design considerations. Tob Control 23:ii4–10.
9. W.Buchser, M.Collins, T.Garyantes,. (2004). Assay development guidelines for image-based high content screening, high content analysis and high content imaging. 2012 Oct 1 [Updated 2014 Sep 22]. In G.S.Sittampalam, N.P.Coussens, H.Nelson,., eds. Assay guidance manual [Internet]. Bethesda (MD):Eli Lilly & Company and the National Center for Advancing Translational Sciences. Available from:https://www.ncbi.nlm.nih.gov/books/NBK100913/.
10. P.Callahan-Lyon (2014). Electronic cigarettes:human health effects. Tob Control 23:ii36–40.
11. W.J.Catallo, C.H.Kennedy, W.Henk,. (2001). Combustion products of 1,3-butadiene are cytotoxic and genotoxic to human bronchial epithelial cells. Environ Health Perspect 109:965–71.
12. W.Chen, C.Wong, E.Vosburgh,. (2014). High-throughput image analysis of tumor spheroids:a user-friendly software application to measure the size of spheroids automatically and accurately. J Vis Exp 89:e51639, doi:10.3791/51639.
13. A.Comouth, H.Saathoff, K.-H.Naumann,. (2013). Modelling and measurement of particle deposition for cell exposure at the air–liquid interface. J Aerosol Sci 63:103–14.
14. S.Constant, L.Wiszniewski, S.Huang (2014). The use of in vitro 3D cell models of human airway epithelia (MucilAirTM) in inhalation toxicity. In J.Haycock, A.Whluwalia, M.Wilkinson, eds. Cellular in vitro testing:methods and protocols. London:CRC Press, 15–33.
15. CORESTA. (2004). The CORESTA E-Cigarette Task Force. The rationale and strategy for conducting in vitro toxicology testing of tobacco smoke. Available from:http://www.coresta.org/Reports/IVT_TF_Rationale-IVT-Testing-Tob.-Smoke_Report_Jun04.pdf.
16. CORESTA. (2015a). The CORESTA E-Cigarette Task Force. Electronic cigarette aerosol parameters study. Available from:http://www.coresta.org/Reports/ECIG-CTR_ECigAerosolParameters-2014Study_March2015.pdf.
17. o 81. Routine analytical machine for e-cigarette aerosol generation and collection – devinitions and standard conditions. Available from:http://www.coresta.org/Recommended_Methods/CRM_81.pdf.
18. C.Costa, R.Rufino, S.L.Traves,. (2008). CXCR3 and CCR5 chemokines in induced sputum from patients with COPD. Chest 133:26–33.
19. S.Costigan, C.Meredith (2015). An approach to ingredient screening and toxicological risk assessment of flavours in e-liquids. Regul Toxicol Pharmacol 72:361–9.
20. L.Crotty Alexander, M.Fuster, P.Montgrain,. (2015). The need for more e-cigarette data:a call to action. Am J Resp Crit Care Med 192:275–6.
21. M.Dai, P.Wang, A.D.Boyd,. (2005). Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33:e175.
22. B.Davis, M.Dang, J.Kim,. (2015). Nicotine concentrations in electronic cigarette refill and do-it-yourself fluids. Nicotine Tob Res 17:134–41.
23. A.Di Stefano, G.Caramori, I.Gnemmi,. (2009). Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD. Thorax 64:968–75.
24. K.O.Fagerström, K.Bridgman (2014). Tobacco harm reduction:the need for new products that can compete with cigarettes. Addict Behav 39:507–11.
25. M.Famele, C.Ferranti, C.Abenavoli,. (2015). The chemical components of electronic cigarette cartridges and refill fluids:review of analytical methods. Nicotine Tob Res 17:271–9.
26. K.E.Farsalinos, J.Le Houezec (2015). Regulation in the face of uncertainty:the evidence on electronic nicotine delivery systems (e-cigarettes). Risk Manag Healthc Policy 8:157–67.
27. K.E.Farsalinos, R.Polosa (2014). Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes:a systematic review. Ther Adv Drug Saf 5:67–86.
28. K.E.Farsalinos, G.Romagna, E.Allifranchini,. (2013). Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health 10:5146–62.
29. K.E.Farsalinos, V.Voudris, K.Poulas (2015). E-cigarettes generate high levels of aldehydes only in ‘dry puff’ conditions. Addiction 110:1352–6.
30. FDA. (2012). Guidance for industry S2(R1) genotoxicity testing and data interpretation for pharmaceuticals intended for human use. Available from:http://www.fda.gov/downloads/Drugs/…/Guidances/ucm074931.pdf.
31. J.W.Flora, N.Meruva, C.B.Huang,. (2016). Characterization of potential impurities and degradation products in electronic cigarette formulations and aerosols. Regul Toxicol Pharmacol 74:1–11.
32. T.Gocht, E.Berggren, H.J.Ahr,. (2015). The SEURAT-1 approach towards animal free human safety assessment. Altex 32:9–24.
33. I.Gonzalez-Suarez, F.Martin, D.Marescotti,. (2016). In vitro systems toxicology assessment of a candidate modified risk tobacco product shows reduced toxicity compared to that of a conventional cigarette. Chem Res Toxicol 29:3–18.
34. I.Gonzalez-Suarez, A.Sewer, P.Walker,. (2014). Systems biology approach for evaluating the biological impact of environmental toxicants in vitro. Chem Res Toxicol 27:367–76.
35. S.A.Haney, D.Bowman, A.Chakravarty,. (2015). An introduction to high content screening:imaging technology, assay development, and data analysis in biology and drug discovery. Wiley. Available from:http://www.books24x7.com/marc.asp?bookid=80823.
36. P.T.Harrell, V.N.Simmons, J.B.Correa,. (2014). Electronic nicotine delivery systems (“e-cigarettes”):review of safety and smoking cessation efficacy. Otolaryngol Head Neck Surg 151:381–93.
37. Health Canada. (1999). Determination of tar, water, nicotine and carbon monoxide in mainstream tobacco smoke. Health Canada Test Method T-11.
38. HHS, FDA, CDER,. (2012). U.S. Department of Health and Human Services (HHS), Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), and Center for Biologics Evaluation and Research (CBER). Guidance for industry. S2(R1) genotoxicity testing and data interpretation for pharmaceuticals intended for human use. Available from:http://www.fda.gov/downloads/Drugs/…/Guidances/ucm074931.pdf.
39. J.Hoeng, M.Talikka, F.Martin,. (2014). Case study:the role of mechanistic network models in systems toxicology. Drug Discov Today 19:183–92.
40. A.F.Hubbs, L.A.Battelli, W.T.Goldsmith,. (2002). Necrosis of nasal and airway epithelium in rats inhaling vapors of artificial butter flavoring. Toxicol Appl Pharmacol 185:128–35.
41. A.F.Hubbs, A.M.Cumpston, W.T.Goldsmith,. (2012). Respiratory and olfactory cytotoxicity of inhaled 2,3-pentanedione in Sprague-Dawley rats. Am J Pathol 181:829–44.
42. J.R.Hughes, J.Keely, S.Naud (2004). Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 99:29–38.
43. IOM. (2001). Institute of Medicine (US) Committee to assess the science base for tobacco harm reduction. In K.Stratton, P.Shetty, R.Wallace,., eds. Clearing the smoke:assessing the science base for tobacco harm reduction. Washington (DC):National Academies Press (US); 2001. 7, Implementation of a Science-Based Policy of Harm Reduction. Available from:http://www.ncbi.nlm.nih.gov/books/NBK222381/.
44. A.R.Iskandar, Y.Xiang, S.Frentzel,. (2015). Impact assessment of cigarette smoke exposure on organotypic bronchial epithelial tissue cultures:a comparison of mono-culture and coculture model containing fibroblasts. Toxicol Sci 147:207–21.
45. C.E.Jones, K.Chan (2002). Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol 26:748–53.
46. I.I.Katkov, N.Katkova, J.K.Critser,. (1998). Mouse spermatozoa in high concentrations of glycerol:chemical toxicity vs osmotic shock at normal and reduced oxygen concentrations. Cryobiology 37:325–38.
47. N.Ke, X.Wang, X.Xu,. (2011). The xCELLigence system for real-time and label-free monitoring of cell viability. Methods Mol Biol 740:33–43.
48. Y.Kikawa, S.Hosoi, Y.Inoue,. (1991). Exercise-induced urinary excretion of leukotriene E4 in children with atopic asthma. Pediatr Res 29:455–9.
49. S.Kim, M.L.Goniewicz, S.Yu,. (2015). Variations in label information and nicotine levels in electronic cigarette refill liquids in South Korea:regulation challenges. Int J Environ Res Public Health 12:4859–68.
50. U.Kogel, I.Gonzalez Suarez, Y.Xiang,. (2015). Biological impact of cigarette smoke compared to an aerosol produced from a prototypic modified risk tobacco product on normal human bronchial epithelial cells. Toxicol in Vitro 29:2102–15.
51. L.Kosmider, A.Sobczak, M.Fik,. (2014). Carbonyl compounds in electronic cigarette vapors—effects of nicotine solvent and battery output voltage. Nicotine Tob Res 16:1319–26.
52. P.L.Leopold, M.J.O’Mahony, X.J.Lian,. (2009). Smoking is associated with shortened airway cilia. PLoS One 4:e8157.
53. C.A.Lerner, I.K.Sundar, H.Yao,. (2015). Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One 10:e0116732.
54. M.Manigrasso, G.Buonanno, F.C.Fuoco,. (2015). Aerosol deposition doses in the human respiratory tree of electronic cigarette smokers. Environ Pollut 196:257–67.
55. D.Marescotti, I.Gonzalez Suarez, S.Acali,. (2015). High content screening analysis to evaluate the toxicological effects of harmful and potentially harmful constituents (HPHC). J Vis Exp.
56. F.Martin, A.Sewer, M.Talikka,. (2014). Quantification of biological network perturbations for mechanistic insight and diagnostics using two-layer causal models. BMC Bioinformatics 15:238.
57. F.Martin, T.M.Thomson, A.Sewer,. (2012). Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networks. BMC Syst Biol 6:54.
58. C.Mathis, C.Poussin, D.Weisensee,. (2013). Human bronchial epithelial cells exposed in vitro to cigarette smoke at the air-liquid interface resemble bronchial epithelium from human smokers. Am J Physiol Lung Cell Mol Physiol 304:L489–503.
59. M.N.McCall, B.M.Bolstad, R.A.Irizarry (2010). Frozen robust multiarray analysis (fRMA). Biostatistics 11:242–53.
60. H.McRobbie, C.Bullen, J.Hartmann-Boyce,. (2014). Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev 12:CD010216.
61. M.Misra, R.D.Leverette, B.T.Cooper,. (2014). Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products:e-liquids, extracts and collected aerosols. Int J Environ Res Public Health 11:11325–47.
62. D.Mortimer, C.L.R.Barratt, L.Björndahl,. (2013). What should it take to describe a substance or product as ‘sperm-safe’. Hum Reprod Update 19:i1–i45.
63. T.Muller, S.Gebel (1994). Heme oxygenase expression in Swiss 3T3 cells following exposure to aqueous cigarette smoke fractions. Carcinogenesis 15:67–72.
64. M.Nordlund, M.Belka, A.K.Kuczaj,. (2015). Aerosol particle deposition measurements in a realistic cast of the human respiratory system. Aerosol Sci Technol (Submitted, under review).
65. G.Oberdörster (2012). Nanotoxicology:in vitro–in vivo dosimetry. Environ Health Perspect 120:a13.
66. M.S.Orr (2014). Electronic cigarettes in the USA:a summary of available toxicology data and suggestions for the future. Tob Control 23:ii18–22.
67. H.-R.Paur, F.R.Cassee, J.Teeguarden,. (2011). In-vitro cell exposure studies for the assessment of nanoparticle toxicity in the lung—a dialog between aerosol science and biology. J Aerosol Sci 42:668–92.
68. R.Polosa, D.Campagna, M.F.Sands (2016). Counseling patients with asthma and allergy about electronic cigarettes:an evidence-based approach. Ann Allergy Asthma Immunol 116:106–11.
69. C.Poussin, A.Laurent, M.C.Peitsch,. (2015). Systems biology reveals cigarette smoke-induced concentration-dependent direct and indirect mechanisms that promote monocyte-endothelial cell adhesion. Toxicol Sci 147:370–85.
70. D.Proud, R.Leigh (2011). Epithelial cells and airway diseases. Immunol Rev 242:186–204.
71. E.Roemer, F.J.Tewes, T.J.Meisgen,. (2002). Evaluation of the potential effects of ingredients added to cigarettes. Part 3:in vitro genotoxicity and cytotoxicity. Food Chem Toxicol 40:105–11.
72. G.Romagna, E.Allifranchini, E.Bocchietto,. (2013). Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE):comparison with tobacco cigarette smoke extract. Inhal Toxicol 25:354–61.
73. C.Rovida, S.Asakura, M.Daneshian,. (2015). Toxicity testing in the 21st century beyond environmental chemicals. Altex 32:171–81.
74. C.Rusznak, P.R.Mills, J.L.Devalia,. (2000). Effect of cigarette smoke on the permeability and IL-1beta and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 23:530–6.
75. S.Scheffler, H.Dieken, O.Krischenowski,. (2015). Evaluation of e-cigarette liquid vapor and mainstream cigarette smoke after direct exposure of primary human bronchial epithelial cells. Int J Environ Res Public Health 12:3915–25.
76. W.K.Schlage, A.R.Iskandar, R.Kostadinova,. (2014). In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures. Toxicol Mech Meth 24:470–87.
77. L.Schwartz, A.Guais, M.Pooya,. (2009). Is inflammation a consequence of extracellular hyperosmolarity? J Inflamm 6:21.
78. J.Seagrave, H.Albrecht, D.Hill,. (2012). Effects of guaifenesin, N-acetylcysteine, and ambroxol on MUC5AC and mucociliary transport in primary differentiated human tracheal-bronchial cells. Resp Res 13:98
79. L.S.Sheldon, E.A.Cohen Hubal (2009). Exposure as part of a systems approach for assessing risk. Environ Health Perspect 117:119–1194.
80. P.C.Shivalingappa, R.Hole, C.V.Westphal,. (2015). Airway exposure to e-cigarette vapors impairs autophagy and induces aggresome formation. Antioxid Redox Signal.
81. O.Sirenko, T.Mitlo, J.Hesley,. (2015). High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures. Assay Drug Dev Technol 13:402–14.
82. C.Smith, J.Djakow, R.Free,. (2012). ciliaFA:a research tool for automated, high-throughput measurement of ciliary beat frequency using freely available software. Cilia 1:14.
83. G.K.Smyth (2004). Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article 3.
84. M.R.Stampfli, G.P.Anderson (2009). How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol 9:377–84.
85. S.J.Sturla, A.R.Boobis, R.E.FitzGerald,. (2014). Systems toxicology:from basic research to risk assessment. Chem Res Toxicol 27:314–29.
86. A.Subramanian, P.Tamayo, V.K.Mootha,. (2005). Gene set enrichment analysis:a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545–50.
87. S.Talih, Z.Balhas, T.Eissenberg,. (2015). Effects of user puff topography, device voltage, and liquid nicotine concentration on electronic cigarette nicotine yield:measurements and model predictions. Nicotine Tob Res 17:150–7.
88. M.Talikka, R.Kostadinova, Y.Xiang,. (2014). The response of human nasal and bronchial organotypic tissue cultures to repeated whole cigarette smoke exposure. Int J Toxicol 33:506–17.
89. X.L.Tan, G.Marquardt, A.B.Massimi,. (2012). High-throughput library screening identifies two novel NQO1 inducers in human lung cells. Am J Respir Cell Mol Biol 46:365–71.
90. T.M.Thomson, A.Sewer, F.Martin,. (2013). Quantitative assessment of biological impact using transcriptomic data and mechanistic network models. Toxicol Appl Pharmacol 272:863–78.
91. D.Thorne, J.Adamson (2013). A review of in vitro cigarette smoke exposure systems. Exp Toxicol Pathol 65:1183–93.
92. P.A.Tierney, C.D.Karpinski, J.E.Brown,. (2015). Flavour chemicals in electronic cigarette fluids. Tob Control. doi:10.1136/tobaccocontrol-2014-052175.
93. A.E.Tilley, M.S.Walters, R.Shaykhiev,. (2015). Cilia dysfunction in lung disease. Annu Rev Physiol 77:379–406.
94. A.Tippe, U.Heinzmann, C.Roth (2002). Deposition of fine and ultrafine aerosol particles during exposure at the air/cell interface. J Aerosol Sci 33:207–18.
95. C.I.Vardavas, I.T.Agaku (2015). Electronic cigarettes:the issues behind the moral quandary. In R.Loddenkemper, M.Kreuter, eds. The tobacco epidemic. Progress in respiratory research. 2nd ed. Basel:Karger Medical and Scientific Publishers vol. 42, 258–67.
96. H.Varma, D.C.Lo, B.R.Stockwell (2011). High-throughput and high-content screening for Huntington’s disease therapeutics. In D.C.Lo, R.E.Hughes, eds. Neurobiology of Huntingon’s disease:applications to drug discovery. Boca Raton (FL):CRC Press/Taylor & Francis, 121–45.
97. J.Wan, M.Johnson, J.Schilz,. (2009). Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco. Cancer Epidemiol Biomarkers Prev 18:3263–304.
98. M.S.Werley, A.M.Jerome, M.J.Oldham (2014). Toxicological evaluation of aerosols of a tobacco extract formulation and nicotine formulation in acute and short-term inhalation studies. Inhal Toxicol 26:207–21.
99. WHO. (2004). Study Group on Tobacco Product Regulation. Recommendation 1:guiding principles for the development of tobacco product research and testing capacity and proposed protocols for the initiation of tobacco product testing. Available from:http://www.who.int/fctc/guidelines/ArtElevenWHOFour.pdf.
100. Q.Wu, D.Jiang, M.Minor,. (2014). Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cells. PLoS One 9:e108342.
101. M.Yamin, E.H.Holbrook, S.T.Gray,. (2008). Cigarette smoke combined with Toll-like receptor 3 signaling triggers exaggerated epithelial regulated upon activation, normal T-cell expressed and secreted/CCL5 expression in chronic rhinosinusitis. J Allergy Clin Immunol 122:1145–53.
102. S.H.Zhu, J.Y.Sun, E.Bonnevie,. (2014). Four hundred and sixty brands of e-cigarettes and counting:implications for product regulation. Tob Control 23:iii3–9.